U.S. pharma big copyright scrapped two experimental weight loss tablets past year—a the moment-everyday pill, lotiglipron, due to elevated liver enzymes and also a twice-day-to-day pill, danuglipron, resulting from strong Uncomfortable side effects—but CEO Albert Bourla has said the